Menu
Back to Journals » Drug Design, Development and Therapy » Volume 16
Retraction
Development of a Nanoliposomal Formulation of Erlotinib for Lung Cancer and in vitro/In vivo Antitumoral Evaluation [Retraction]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 2,105 | Dovepress* | 2,025+ | 54 | 2,079 | |
| PubMed Central* | 80 | 44 | 124 | ||
| Totals | 2,105 | 98 | 2,203 | ||
| *Since 18 November 2022 | |||||
View citations on PubMed Central and Google Scholar